JUL 29, 2015 1:55 PM PDT

Hundred-Cell Epigenomic Analysis Pumps Up Personalized Medicine

WRITTEN BY: Ilene Schneider
Personalized medicine could get a big boost from a new technique that is said to reduce the number of cells needed for epigenomic analysis from millions to just 100, according to an article written by Bevin Fletcher, associate editor, in Bioscience Technology. Fletcher explains that epigenome investigation requires DNA interaction mapping with a certain protein in the whole genome, enabling physicians to obtain a fuller picture of the state of the patient and develop a personalized treatment strategy. Because the procedure used to take about 10 million cells for a single test to study in vivo genome-wide protein-DNA interactions and chromatin modifications, this kind of analysis was impractical (http://www.biosciencetechnology.com/articles/2015/07/new-technique-allows-epigenomic-analysis-just-100-cells?et_cid=4699918&et_rid=45505806&type=cta).
Researchers say that they have developed a new epigenomics technique that can make personalized medicine a reality.
Now a new technology that improves the efficiency of epigenomic studies is described in a Nature Methods journal article by Chang Lu and Zhenning Cao of Virginia Tech and Kai Tan, Changya Chen and Bing He of the University of Iowa. The National Institutes of Health funded the research, after a seed grant from Virginia Tech's Institute for Critical Technology and Applied Science (http://scifeeds.com/news/technology-helps-personalized-medicine-enabling-epigenomic-analysis-with-a-mere-100-cells/).

In the laboratory Chang Lu, professor of chemical engineering at Virginia Tech, and his students designed a small microfluidic device with micrometer features to examine cells at a molecular level. Microfluidic oscillatory washing based chromatin immunoprecipitation (MOWChIP-Seq) was the result of a collaboration between Profs. Lu and Tan. Prof. Tan is a systems biologist and associate professor of internal medicine at the University of Iowa. The new technology assesses epigenome interactions in 90 minutes as compared to the conventional ChIP assays that had required several hours and much larger samples.

According to Prof. Lu's comments in a press release from Virginia Tech, which filed a U.S. utility patent on the technology on behalf of Prof. Lu, "The use of a packed bed of beads for ChIP allowed us to collect the chromatin fragments with a very high efficiency. At the same time, effective washing for removing undesired molecules and debris guarantees the purity of the collected molecules. These two factors constitute a successful strategy for epigenomic analysis with extremely high sensitivity."

Prof. Lu adds that the research team's next planned project is to use the new technology to study changes in the epigenome associated with cancer and inflammation. He concludes, Our technology paves the way for studies of epigenomes with extremely low number of cells from animals and from patients."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
APR 27, 2020
Genetics & Genomics
New Insight Into HIV Opens Path to Better Therapeutics
APR 27, 2020
New Insight Into HIV Opens Path to Better Therapeutics
Researchers have made a breakthrough in our understanding of HIV infections.
APR 28, 2020
Genetics & Genomics
Evolution Observed in Fish in a Single Generation
APR 28, 2020
Evolution Observed in Fish in a Single Generation
In a five year study, scientists have now shown that stickleback fish were able to alter some of their traits within a s ...
JUN 22, 2020
Cancer
Methylation Markers That Can be Used to Diagnose Pancreatic Cancer
JUN 22, 2020
Methylation Markers That Can be Used to Diagnose Pancreatic Cancer
Diagnostic tests are the unsung heroes of cancer treatment. While there are more treatments for cancer coming out every ...
JUL 19, 2020
Genetics & Genomics
Genetic Surveys Could Help Save Coral Reefs
JUL 19, 2020
Genetic Surveys Could Help Save Coral Reefs
Coral reefs are a significant source of biodiversity and may support up to 25% of life in the ocean. Corals around the w ...
JUL 27, 2020
Plants & Animals
Why Mosquitoes Have a Preference for Human Blood
JUL 27, 2020
Why Mosquitoes Have a Preference for Human Blood
There is a huge variety of mosquitoes in the world - around 3,500 species - and only a few seek humans for their blood m ...
AUG 02, 2020
Genetics & Genomics
In a First, Researchers Edit Cephalopod Genes
AUG 02, 2020
In a First, Researchers Edit Cephalopod Genes
Using the CRISPR-Cas9 gene-editing tool, researchers have knocked out a gene in a cephalopod for the first time.
Loading Comments...